Riskpilot← Back to searchSign inGet full accessLYSAKER OPTIKK AS
ASActiveOrg 996261182Lysaker Torg 5, 1366 LysakerRetail sale of medical and orthopaedic goods · NACE 4774Est. 20101 employees
Revenue 2024
NOK 1,4M
-17% vs 2023
EBITDA margin
-12.1%
-200% vs 2023
Equity ratio
-239.6%
Financial strength
Net profit 2024
NOK -174K
-176% vs 2023
| Revenue | NOK 1,4M | -17% |
| EBITDA | NOK -174K | -200% |
| Net profit | NOK -174K | -176% |
| Total assets | NOK 260K | -53% |
| Equity | NOK -624K | -1095% |
| Employees | 1 | — |
Legal name
LYSAKER OPTIKK AS
Org number
996261182
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
14. november 2010
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Jermund florentz
Company purpose
Fremstilling/salg av briller, kontaktlinser, og andre produkter og tjenester som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Lysaker Torg 5, 1366 Lysaker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 513 | 1 109 | 1 446 | 1 721 | 1 434 |
| Staff expenses | −445 | −455 | −658 | −763 | −590 |
| EBITDA | 98 | −184 | −190 | 173 | −174 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 98 | −184 | −190 | 173 | −174 |
| Net financials | 12 | 15 | 21 | 23 | −1 |
| Profit before tax | 110 | −169 | −169 | 196 | −174 |
| Tax | 18 | 11 | 37 | −33 | −0 |
| Net profit | 92 | −181 | −207 | 229 | −174 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 549 | 511 | 396 | 553 | 260 |
| Equity | 217 | 36 | −170 | 63 | −624 |
| Long-term debt | 0 | 0 | 17 | 0 | 375 |
| Short-term debt | 332 | 475 | 548 | 490 | 508 |
| Total debt | 332 | 475 | 566 | 490 | 884 |
EBITDA margin
-12.1%
This company
15.8%
Market median
-177% vs market
20202024
Equity ratio
-239.6%
This company
38.2%
Market median
-727% vs market
20202024
Return on equity
-17417900.0%
This company
18.4%
Market median
-94662600% vs market
20202024
Net profit margin
-12.1%
This company
8.1%
Market median
-249% vs market
20202024
Asset turnover
5.51×
This company
1.12×
Market median
+392% vs market
20202024
Debt / equity
1.42×
This company
0.62×
Market median
-129% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
OF Deputy Member | Deputy Member | 2010 |
JF Chief Executive Officer | Chief Executive Officer | 2010 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LYSAKER OPTIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olaf Florentz | Deputy Member | 0 companies |
| Jermund Florentz | Chief Executive Officer | 0 companies |